Call Us + 33 1 84 88 31 00

Article R1142-63-33 of the French Public Health Code

When the condition of the person who has suffered damage is consolidated after the date on which the college issued its first opinion, or when new damage resulting from a worsening of the person’s state of health attributable to sodium valproate or one of its derivatives requires a new assessment of the damage, this person or his successors may ask the college of experts to issue a new opinion.

The request is examined in accordance with the conditions set out in Articles R. 1142-63-24 to R. 1142-63-32, without it being necessary, however, to re-examine whether the claimant can provide evidence of bodily injury attributable to sodium valproate or one of its derivatives.

Original in French 🇫🇷
Article R1142-63-33

Lorsque la consolidation de l’état de la personne ayant subi des dommages est postérieure à la date à laquelle le collège a rendu un premier avis ou lorsque des préjudices nouveaux consécutifs à une aggravation de l’état de santé de la personne imputable au valproate de sodium ou à l’un de ses dérivés nécessitent une nouvelle évaluation des dommages, cette personne ou ses ayants droit peuvent demander au collège d’experts d’émettre un nouvel avis.

La demande est instruite dans les conditions prévues aux articles R. 1142-63-24 à R. 1142-63-32, sans qu’il y ait toutefois lieu de rechercher à nouveau si le demandeur justifie d’un dommage corporel imputable au valproate de sodium ou à l’un de ses dérivés.

Need help with this article? Get help from a French lawyer

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call us at +33 (0) 1 84 88 31 00 or send us an email.

Useful links

You have a question in French Business Law?

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call +33 (0) 1 84 88 31 00 or send us an email.

All information exchanged through this website will be communicated to lawyers registered with a French Bar and will remain confidential.